Abstract 110: Genetic Analysis Implicates LDL Cholesterol Reduction and Plasminogen Activator-inhibitor 1 Antagonism as Therapeutic Interventions for Venous Thromboembolism

Derek Klarin(Stanford University), John Concato(Yale University), Peter D. Reaven(Phoenix VA Health Care System), Marijana Vujković(Philadelphia VA Medical Center), Themistocles L. Assimes(Stanford University), Jennifer E. Huffman(Harvard University), Julie Lynch(VA Salt Lake City Healthcare System), Mary E. Haas(Broad Institute), Emma Busenkell(Massachusetts General Hospital), Danish Saleheen(Columbia University Irving Medical Center), Scott L. DuVall(University of Utah), Kyong‐Mi Chang(Philadelphia VA Medical Center), Yan V. Sun(Utah State University), Sekar Kathiresan(Massachusetts General Hospital), Renae Judy(University of Pennsylvania), Krishna G. Aragam(Massachusetts General Hospital), Pradeep Natarajan(Unknown), Kelly Cho(VA Boston Healthcare System), Saiju Pyarajan(Brigham and Women's Hospital), Philip S. Tsao(Stanford University), Mark Chaffin(Broad Institute), Daniel J. Rader(University of Pennsylvania), William E. Boden(VA New England Healthcare System), Qing Shao(Newman University), Scott M. Damrauer(Philadelphia VA Medical Center), Christopher J. O’Donnell(Harvard University), Yunfeng Huang(Emory University), Kyung Min Lee(VA Salt Lake City Healthcare System), Jie Huang(Sun Yat-sen University), Nicholas L. Smith(University of Washington), Donald R. Miller(University of Massachusetts Lowell), Peter W.F. Wilson(VA Tennessee Valley Healthcare System), J. Michael Gaziano(Brigham and Women's Hospital)
Arteriosclerosis Thrombosis and Vascular Biology
May 1, 2019
Cited by 0


Related Papers